Aura Biosciences Inc
NASDAQ:AURA

Watchlist Manager
Aura Biosciences Inc Logo
Aura Biosciences Inc
NASDAQ:AURA
Watchlist
Price: 10.33 USD -3% Market Closed
Market Cap: 512.5m USD
Have any thoughts about
Aura Biosciences Inc?
Write Note

Wall Street
Price Targets

AURA Price Targets Summary
Aura Biosciences Inc

Wall Street analysts forecast AURA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AURA is 22.44 USD with a low forecast of 20.2 USD and a high forecast of 24.15 USD.

Lowest
Price Target
20.2 USD
96% Upside
Average
Price Target
22.44 USD
117% Upside
Highest
Price Target
24.15 USD
134% Upside

AURA Last Price Targets
Aura Biosciences Inc

The latest public price target was made on Oct 18, 2024 by Julian Harrison from BTIG , who expects AURA stock to rise by 132% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Julian Harrison
BTIG
24 USD
Upside 132%
3 weeks ago
Oct 18, 2024
Aura Biosciences (AURA) PT Raised to $24 at BTIG
StreetInsider
George Farmer
Scotiabank
23 USD
Upside 123%
3 weeks ago
Oct 18, 2024
Aura Biosciences (AURA) PT Raised to $23 at Scotiabank
StreetInsider
Ed White II
H.C. Wainwright
22 USD
Upside 113%
3 weeks ago
Oct 18, 2024
Aura Biosciences (AURA) PT Raised to $22 at H.C. Wainwright
StreetInsider
Edward White
H.C. Wainwright
21 USD
Upside 103%
3 months ago
Jul 25, 2024
Aura Biosciences initiated with a Buy at H.C. Wainwright
TheFly
Julian Harrison
BTIG
Price Target 24 USD
Upside/Downside 132%
View Source
George Farmer
Scotiabank
Price Target 23 USD
Upside/Downside 123%
View Source
Ed White II
H.C. Wainwright
Price Target 22 USD
Upside/Downside 113%
View Source
Edward White
H.C. Wainwright
Price Target 21 USD
Upside/Downside 103%
View Source
Aura Biosciences Inc Competitors:
Price Targets
VCYT
Veracyte Inc
4% Downside
CAPR
Capricor Therapeutics Inc
131% Upside
1801
Innovent Biologics Inc
59% Upside
251120
Bio-FD&C Co Ltd
48% Upside
MAB
Mabion SA
37% Upside
603087
Gan & Lee Pharmaceuticals
39% Upside
BCRX
BioCryst Pharmaceuticals Inc
93% Upside

Revenue
Forecast

Revenue Estimate
Aura Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Aura Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Aura Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AURA's stock price target?
Price Target
22.44 USD

According to Wall Street analysts, the average 1-year price target for AURA is 22.44 USD with a low forecast of 20.2 USD and a high forecast of 24.15 USD.

Back to Top